TipRanks
Oncopeptides AB (DE:OND)
FRANKFURT:OND
Germany Market
OND
Oncopeptides AB
RESEARCH TOOLSreports

Oncopeptides AB (OND) Cash flow

6 Followers

Oncopeptides AB Cash Flow

DE:OND's free cash flow for Q2 2026 was kr-42.81M. For the 2026 fiscal year, DE:OND's free cash flow was decreased by kr37.69M and operating cash flow was kr-42.81M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
kr -222.88Mkr -260.57Mkr -279.49Mkr -420.51Mkr -1.52B
Investing Cash Flow
kr 0.00kr 496.00Kkr -116.00Kkr -2.51Mkr -339.00K
Financing Cash Flow
kr 128.55Mkr 263.81Mkr 106.89Mkr 392.40Mkr 1.03B
End Cash Position
kr 82.25Mkr 178.54Mkr 173.41Mkr 344.51Mkr 362.19M
Free Cash Flow
kr -222.88Mkr -260.57Mkr -279.61Mkr -423.02Mkr -1.52B
Currency in SEK

Oncopeptides AB Cash Flow